Publication | Closed Access

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

VaccinologyVaccine SafetyVaccinationReverse VaccinologyMedicineRandomised TrialsImmunologyVaccine EfficacyRoutine InfantInfection ControlBacterial MeningitisChild VaccinationsVaccine Research